These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12115877)
1. Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2. Bartosová M; Parkkila S; Pohlodek K; Karttunen TJ; Galbavý S; Mucha V; Harris AL; Pastorek J; Pastoreková S J Pathol; 2002 Jul; 197(3):314-21. PubMed ID: 12115877 [TBL] [Abstract][Full Text] [Related]
2. Detection of carbonic anhydrase 9-expressing tumor cells in the lymph nodes of vulvar carcinoma patients by RT-PCR. Kowalewska M; Radziszewski J; Kulik J; Barathova M; Nasierowska-Guttmajer A; Bidziński M; Pastorek J; Pastorekova S; Siedlecki JA Int J Cancer; 2005 Oct; 116(6):957-62. PubMed ID: 15856466 [TBL] [Abstract][Full Text] [Related]
3. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Uemura H; Nakagawa Y; Yoshida K; Saga S; Yoshikawa K; Hirao Y; Oosterwijk E Br J Cancer; 1999 Oct; 81(4):741-6. PubMed ID: 10574265 [TBL] [Abstract][Full Text] [Related]
4. [MN/CA IX antigen as a potential target for renal cell carcinoma]. Uemura H; Cho M; Nakagawa Y; Shimizu K; Yoshikawa M; Kim S; Hirao Y Hinyokika Kiyo; 2000 Oct; 46(10):745-8. PubMed ID: 11215204 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients. Kaya AO; Gunel N; Benekli M; Akyurek N; Buyukberber S; Tatli H; Coskun U; Yildiz R; Yaman E; Ozturk B J BUON; 2012; 17(4):663-8. PubMed ID: 23335522 [TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome. Span PN; Bussink J; Manders P; Beex LV; Sweep CG Br J Cancer; 2003 Jul; 89(2):271-6. PubMed ID: 12865916 [TBL] [Abstract][Full Text] [Related]
7. MN/CA9: a potential gene marker for detection of malignant cells in effusions. Li G; Passebosc-Faure K; Feng G; Lambert C; Cottier M; Gentil-Perret A; Fournel P; Pérol M; Genin C Biomarkers; 2007; 12(2):214-20. PubMed ID: 17536770 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical reevaluation of carbonic anhydrase IX (CA IX) expression in tumors and normal tissues. Luong-Player A; Liu H; Wang HL; Lin F Am J Clin Pathol; 2014 Feb; 141(2):219-25. PubMed ID: 24436269 [TBL] [Abstract][Full Text] [Related]
11. Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma. Tanaka N; Kato H; Inose T; Kimura H; Faried A; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Fukuchi M; Kuwano H Br J Cancer; 2008 Nov; 99(9):1468-75. PubMed ID: 18841153 [TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438 [TBL] [Abstract][Full Text] [Related]
13. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538 [TBL] [Abstract][Full Text] [Related]
14. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Brennan DJ; Jirstrom K; Kronblad A; Millikan RC; Landberg G; Duffy MJ; Rydén L; Gallagher WM; O'Brien SL Clin Cancer Res; 2006 Nov; 12(21):6421-31. PubMed ID: 17085655 [TBL] [Abstract][Full Text] [Related]
15. Expression of carbonic anhydrase 9 at the invasion front of gastric cancers. Chen J; Röcken C; Hoffmann J; Krüger S; Lendeckel U; Rocco A; Pastorekova S; Malfertheiner P; Ebert MP Gut; 2005 Jul; 54(7):920-7. PubMed ID: 15951534 [TBL] [Abstract][Full Text] [Related]
16. Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines. Hunakova L; Bodo J; Chovancova J; Sulikova G; Pastorekova S; Sedlak J Neoplasma; 2007; 54(6):541-8. PubMed ID: 17949239 [TBL] [Abstract][Full Text] [Related]
17. The use of MN/CA9 gene expression in identifying malignant solid renal tumors. Li G; Cuilleron M; Cottier M; Gentil-Perret A; Lambert C; Genin C; Tostain J Eur Urol; 2006 Feb; 49(2):401-5. PubMed ID: 16387417 [TBL] [Abstract][Full Text] [Related]
18. Necrosis and hypoxia in invasive breast carcinoma. Tomes L; Emberley E; Niu Y; Troup S; Pastorek J; Strange K; Harris A; Watson PH Breast Cancer Res Treat; 2003 Sep; 81(1):61-9. PubMed ID: 14531498 [TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer. Simi L; Venturini G; Malentacchi F; Gelmini S; Andreani M; Janni A; Pastorekova S; Supuran CT; Pazzagli M; Orlando C Lung Cancer; 2006 Apr; 52(1):59-66. PubMed ID: 16513206 [TBL] [Abstract][Full Text] [Related]
20. CA9 as a molecular marker for differential diagnosis of cystic renal tumors. Li G; Bilal I; Gentil-Perret A; Feng G; Zhao A; Peoc'h M; Genin C; Tostain J; Gigante M Urol Oncol; 2012; 30(4):463-8. PubMed ID: 20822935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]